Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1997 Apr;71(4):2747–2756. doi: 10.1128/jvi.71.4.2747-2756.1997

Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.

R R Tönjes 1, C Limbach 1, R Löwer 1, R Kurth 1
PMCID: PMC191397  PMID: 9060628

Abstract

The human endogenous retrovirus type K (HERV-K) family codes for the human teratocarcinoma-derived retrovirus (HTDV) particles. The existence of the envelope protein (ENV) of HERV-K encoded by the subgenomic env mRNA has not yet been demonstrated. To study the genetic requirements for successful expression of ENV, we have constructed a series of recombinant HERV-K env expression vectors for infection and transfection experiments in insect cells and mammalian cells, respectively. Six baculovirus constructs bearing full-length or truncated HERV-K env with or without homologous or heterologous signal peptides were used for infections of insect cells. All recombinant baculoviruses yielded ENV proteins with the expected molecular masses. The full-length 80- to 90-kDa HERV-K ENV protein including the cORF leader sequence was glycosylated in insect cells. In addition, the 14-kDa cORF protein was expressed due to splicing of the full-length env mRNA. The ENV precursor protein is not cleaved to the surface (SU) and transmembrane (TM) glycoproteins; it does not appear on the surface of infected insect cells and is not secreted into the medium. For ENV expression in COS cells, plasmid vectors harboring the cytomegalovirus immediate-early promoter/intron A element and the tissue plasminogen activator (t-PA) signal peptide or the homologous HERV-K signal peptide upstream of the env gene were employed. Glycosylated and uncleaved ENV was expressed as in GH teratocarcinoma cells but at higher levels. The heterologous t-PA signal sequence was instrumental for expression of HERV-K ENV on the cell surface. Hence, we have shown for the first time that the HERV-K env gene has the potential to be expressed as a full-length envelope protein with appropriate glycosylation. In addition, our data provide explanations for the lack of infectivity of HERV-K/HTDV particles.

Full Text

The Full Text of this article is available as a PDF (935.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arp J., Ford C. M., Palker T. J., King E. E., Dekaban G. A. Expression and immunogenicity of the entire human T cell leukaemia virus type I envelope protein produced in a baculovirus system. J Gen Virol. 1993 Feb;74(Pt 2):211–222. doi: 10.1099/0022-1317-74-2-211. [DOI] [PubMed] [Google Scholar]
  2. Bedgood R. M., Snider L. D., Stallcup M. R. Maturation of mouse mammary tumor virus envelope protein is blocked by a specific point mutation. Virology. 1992 Jul;189(1):393–396. doi: 10.1016/0042-6822(92)90723-3. [DOI] [PubMed] [Google Scholar]
  3. Boller K., König H., Sauter M., Mueller-Lantzsch N., Löwer R., Löwer J., Kurth R. Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. Virology. 1993 Sep;196(1):349–353. doi: 10.1006/viro.1993.1487. [DOI] [PubMed] [Google Scholar]
  4. Boyd M. T., Bax C. M., Bax B. E., Bloxam D. L., Weiss R. A. The human endogenous retrovirus ERV-3 is upregulated in differentiating placental trophoblast cells. Virology. 1993 Oct;196(2):905–909. doi: 10.1006/viro.1993.1556. [DOI] [PubMed] [Google Scholar]
  5. Chapman B. S., Thayer R. M., Vincent K. A., Haigwood N. L. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res. 1991 Jul 25;19(14):3979–3986. doi: 10.1093/nar/19.14.3979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Henderson L. E., Sowder R., Smythers G., Oroszlan S. Terminal amino acid sequences and proteolytic cleavage sites of mouse mammary tumor virus env gene products. J Virol. 1983 Oct;48(1):314–319. doi: 10.1128/jvi.48.1.314-319.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Horton R. M., Hunt H. D., Ho S. N., Pullen J. K., Pease L. R. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 1989 Apr 15;77(1):61–68. doi: 10.1016/0378-1119(89)90359-4. [DOI] [PubMed] [Google Scholar]
  8. Huang M. T., Gorman C. M. Intervening sequences increase efficiency of RNA 3' processing and accumulation of cytoplasmic RNA. Nucleic Acids Res. 1990 Feb 25;18(4):937–947. doi: 10.1093/nar/18.4.937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Huang M. T., Gorman C. M. The simian virus 40 small-t intron, present in many common expression vectors, leads to aberrant splicing. Mol Cell Biol. 1990 Apr;10(4):1805–1810. doi: 10.1128/mcb.10.4.1805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jarvis D. L., Summers M. D. Glycosylation and secretion of human tissue plasminogen activator in recombinant baculovirus-infected insect cells. Mol Cell Biol. 1989 Jan;9(1):214–223. doi: 10.1128/mcb.9.1.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kornfeld R., Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem. 1985;54:631–664. doi: 10.1146/annurev.bi.54.070185.003215. [DOI] [PubMed] [Google Scholar]
  12. Kozak M. An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol. 1991 Nov;115(4):887–903. doi: 10.1083/jcb.115.4.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kozak M. Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes. Nucleic Acids Res. 1981 Oct 24;9(20):5233–5252. doi: 10.1093/nar/9.20.5233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  15. Larsson E., Kato N., Cohen M. Human endogenous proviruses. Curr Top Microbiol Immunol. 1989;148:115–132. doi: 10.1007/978-3-642-74700-7_4. [DOI] [PubMed] [Google Scholar]
  16. Leavitt R., Schlesinger S., Kornfeld S. Tunicamycin inhibits glycosylation and multiplication of Sindbis and vesicular stomatitis viruses. J Virol. 1977 Jan;21(1):375–385. doi: 10.1128/jvi.21.1.375-385.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lu S., Arthos J., Montefiori D. C., Yasutomi Y., Manson K., Mustafa F., Johnson E., Santoro J. C., Wissink J., Mullins J. I. Simian immunodeficiency virus DNA vaccine trial in macaques. J Virol. 1996 Jun;70(6):3978–3991. doi: 10.1128/jvi.70.6.3978-3991.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Löwer R., Boller K., Hasenmaier B., Korbmacher C., Müller-Lantzsch N., Löwer J., Kurth R. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4480–4484. doi: 10.1073/pnas.90.10.4480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Löwer R., Löwer J., Frank H., Harzmann R., Kurth R. Human teratocarcinomas cultured in vitro produce unique retrovirus-like viruses. J Gen Virol. 1984 May;65(Pt 5):887–898. doi: 10.1099/0022-1317-65-5-887. [DOI] [PubMed] [Google Scholar]
  20. Löwer R., Löwer J., Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci U S A. 1996 May 28;93(11):5177–5184. doi: 10.1073/pnas.93.11.5177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Löwer R., Löwer J., Tondera-Koch C., Kurth R. A general method for the identification of transcribed retrovirus sequences (R-U5 PCR) reveals the expression of the human endogenous retrovirus loci HERV-H and HERV-K in teratocarcinoma cells. Virology. 1993 Feb;192(2):501–511. doi: 10.1006/viro.1993.1066. [DOI] [PubMed] [Google Scholar]
  22. Löwer R., Tönjes R. R., Korbmacher C., Kurth R., Löwer J. Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J Virol. 1995 Jan;69(1):141–149. doi: 10.1128/jvi.69.1.141-149.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Marrack P., Kushnir E., Kappler J. A maternally inherited superantigen encoded by a mammary tumour virus. Nature. 1991 Feb 7;349(6309):524–526. doi: 10.1038/349524a0. [DOI] [PubMed] [Google Scholar]
  24. McDowell W., Schwarz R. T. Dissecting glycoprotein biosynthesis by the use of specific inhibitors. Biochimie. 1988 Nov;70(11):1535–1549. doi: 10.1016/0300-9084(88)90290-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mount S. M. A catalogue of splice junction sequences. Nucleic Acids Res. 1982 Jan 22;10(2):459–472. doi: 10.1093/nar/10.2.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Mueller-Lantzsch N., Sauter M., Weiskircher A., Kramer K., Best B., Buck M., Grässer F. Human endogenous retroviral element K10 (HERV-K10) encodes a full-length gag homologous 73-kDa protein and a functional protease. AIDS Res Hum Retroviruses. 1993 Apr;9(4):343–350. doi: 10.1089/aid.1993.9.343. [DOI] [PubMed] [Google Scholar]
  27. Murphy C. I., Lennick M., Lehar S. M., Beltz G. A., Young E. Temporal expression of HIV-1 envelope proteins in baculovirus-infected insect cells: implications for glycosylation and CD4 binding. Genet Anal Tech Appl. 1990 Oct;7(6):160–171. doi: 10.1016/0735-0651(90)90030-j. [DOI] [PubMed] [Google Scholar]
  28. Ono M., Yasunaga T., Miyata T., Ushikubo H. Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J Virol. 1986 Nov;60(2):589–598. doi: 10.1128/jvi.60.2.589-598.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pancino G., Ellerbrok H., Sitbon M., Sonigo P. Conserved framework of envelope glycoproteins among lentiviruses. Curr Top Microbiol Immunol. 1994;188:77–105. doi: 10.1007/978-3-642-78536-8_5. [DOI] [PubMed] [Google Scholar]
  30. Rasmussen L., Greenwood J. D., Gonda M. A. Expression of bovine immunodeficiency-like virus envelope glycoproteins by a recombinant baculovirus in insect cells. Virology. 1992 Feb;186(2):551–561. doi: 10.1016/0042-6822(92)90021-g. [DOI] [PubMed] [Google Scholar]
  31. Redmond S. M., Dickson C. Sequence and expression of the mouse mammary tumour virus env gene. EMBO J. 1983;2(1):125–131. doi: 10.1002/j.1460-2075.1983.tb01393.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rusche J. R., Lynn D. L., Robert-Guroff M., Langlois A. J., Lyerly H. K., Carson H., Krohn K., Ranki A., Gallo R. C., Bolognesi D. P. Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6924–6928. doi: 10.1073/pnas.84.19.6924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schwarz R. T., Datema R. The lipid pathway of protein glycosylation and its inhibitors: the biological significance of protein-bound carbohydrates. Adv Carbohydr Chem Biochem. 1982;40:287–379. doi: 10.1016/s0065-2318(08)60111-0. [DOI] [PubMed] [Google Scholar]
  34. Sisk W. P., Bradley J. D., Leipold R. J., Stoltzfus A. M., Ponce de Leon M., Hilf M., Peng C., Cohen G. H., Eisenberg R. J. High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells. J Virol. 1994 Feb;68(2):766–775. doi: 10.1128/jvi.68.2.766-775.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Steinhuber S., Brack M., Hunsmann G., Schwelberger H., Dierich M. P., Vogetseder W. Distribution of human endogenous retrovirus HERV-K genomes in humans and different primates. Hum Genet. 1995 Aug;96(2):188–192. doi: 10.1007/BF00207377. [DOI] [PubMed] [Google Scholar]
  36. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Tönjes R. R., Löwer R., Boller K., Denner J., Hasenmaier B., Kirsch H., König H., Korbmacher C., Limbach C., Lugert R. HERV-K: the biologically most active human endogenous retrovirus family. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 (Suppl 1):S261–S267. doi: 10.1097/00042560-199600001-00039. [DOI] [PubMed] [Google Scholar]
  38. Venables P. J., Brookes S. M., Griffiths D., Weiss R. A., Boyd M. T. Abundance of an endogenous retroviral envelope protein in placental trophoblasts suggests a biological function. Virology. 1995 Aug 20;211(2):589–592. doi: 10.1006/viro.1995.1442. [DOI] [PubMed] [Google Scholar]
  39. Walter P., Johnson A. E. Signal sequence recognition and protein targeting to the endoplasmic reticulum membrane. Annu Rev Cell Biol. 1994;10:87–119. doi: 10.1146/annurev.cb.10.110194.000511. [DOI] [PubMed] [Google Scholar]
  40. von Heijne G. A new method for predicting signal sequence cleavage sites. Nucleic Acids Res. 1986 Jun 11;14(11):4683–4690. doi: 10.1093/nar/14.11.4683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. von Heijne G. How signal sequences maintain cleavage specificity. J Mol Biol. 1984 Feb 25;173(2):243–251. doi: 10.1016/0022-2836(84)90192-x. [DOI] [PubMed] [Google Scholar]
  42. von Heijne G. Signal sequences. The limits of variation. J Mol Biol. 1985 Jul 5;184(1):99–105. doi: 10.1016/0022-2836(85)90046-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES